Wednesday - January 7, 2026
FDA Issues Warning Letter to Devalingam Mahalingam, M.D., Ph.D.
December 30, 2025
WASHINGTON, Dec. 30 -- The U.S. Department of Health and Human Services Food and Drug Administration issued the following warning letter to Devalingam Mahalingam, M.D., Ph.D. from the Center for Drug Evaluation and Research:

* * *

Recipient: Devalingam Mahalingam, M.D., Ph.D., 676 North Saint Clair Street, Suite 1200, Chicago, IL 60611-3068, United States

Issuing Office: Center for Drug Evaluation and Research (CDER), United States

WARNING LETT . . .

Targeted News Service Document Request Form

This document is available to you by e-mail if you complete the form below with relevant information. There may be a fee for this article or ongoing service of similar materials. We will be in touch shortly.

Name:
What's your
Affiliation		 Government Newspaper / Media Business
Public Policy Individual / Student Educators
Email:
Phone:
Organization, if any:
State/Country you are in:
Additonal questions
or comments:

Click here for more information about our products

Click here for more information about our products